Home » Stocks » MED » Statistics

Medifast, Inc. (MED)

Stock Price: $274.22 USD -10.06 (-3.54%)
Updated Jul 27, 2021 4:00 PM EDT - Market closed

Total Valuation

Medifast has a market cap or net worth of $3.34 billion. The enterprise value is $3.14 billion.

Market Cap 3.34B
Enterprise Value 3.14B

Important Dates

The next estimated earnings date is August 4, 2021, which is a Wednesday.

Estimated Earnings Date Aug 4, 2021
Ex-Dividend Date Jun 21, 2021

Share Statistics

Medifast has 11.77 million shares outstanding.

Shares Outstanding 11.77M
Share Change (YoY) n/a
Share Change (QoQ) +0.01%
Owned by Insiders (%) 4.41%
Owned by Institutions (%) 85.14%
Float 10.37M

Valuation Ratios

The trailing PE ratio is 25.92.

PE Ratio 25.92
Forward PE n/a
PS Ratio 3.05
PB Ratio 19.12
P/FCF Ratio 19.26
PEG Ratio 1.95
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.36, with a EV/FCF ratio of 18.09.

EV / Earnings 25.04
EV / Sales 2.86
EV / EBITDA 18.36
EV / EBIT 19.21
EV / FCF 18.09

Financial Position

The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.06.

Current Ratio 1.95
Quick Ratio 1.47
Debt / Equity 0.06
Debt / EBITDA 0.06
Debt / FCF 0.06

Financial Efficiency

Return on equity (ROE) is 87.83%, which is very high. The company has a high ROIC of 7,288.50%.

Return on Equity (ROE) 87.83%
Return on Assets (ROA) 38.94%
Return on Capital (ROIC) 7,288.50%
Revenue Per Employee $1.54M
Profits Per Employee $175,940
Employee Count 713
Asset Turnover 4.01
Inventory Turnover 5.19

Taxes

In the past 12 months, Medifast has paid $38.04 million in income taxes. This is 3.47% of the company's revenue.

Income Tax 38.04M
Effective Tax Rate 23.27%
Taxes as % of Revenue 3.47%

Stock Price Statistics

The stock price has increased by +77.72% in the last 52 weeks. The beta is 1.44, so Medifast's price volatility has been higher than the market average.

Beta (1Y) 1.44
52-Week Price Change +77.72%
50-Day Moving Average 279.12
200-Day Moving Average 257.79
Average Volume (30 Days) 80,155

Short Selling Information

The latest short interest is 391,804, so 3.33% of the outstanding shares have been sold short.

Short Interest 391,804
Short % of Shares Out 3.33%
Short Ratio (days to cover) 4.01

Income Statement

In the last 12 months, Medifast had revenue of $1.10 billion and earned $125.45 million in profits. Earnings per share was $10.58.

Revenue 1.10B
Gross Profit 811.12M
Operating Income 163.43M
Pretax Income 163.48M
Net Income 125.45M
EBITDA 171.11M
EBIT 163.48M
Earnings Per Share (EPS) $10.58
Full Income Statement

Balance Sheet

The company has $212.91 million in cash and $10.25 million in debt, giving a net cash position of $202.66 million or $17.22 per share.

Cash & Cash Equivalents 212.91M
Total Debt 10.25M
Net Cash 202.66M
Net Cash Per Share $17.22
Book Value 174.89M
Book Value Per Share 14.86
Working Capital 136.96M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $183.79 million and capital expenditures -$10.19 million, giving a free cash flow of $173.60 million.

Operating Cash Flow 183.79M
Capital Expenditures -10.19M
Free Cash Flow 173.60M
FCF Per Share $14.75
Cash Flow Statement

Margins

Gross margin is 73.94%, with operating and profit margins of 14.90% and 11.43%.

Gross Margin 73.94%
Operating Margin 14.90%
Pretax Margin 14.90%
Profit Margin 11.43%
EBITDA Margin 15.60%
EBIT Margin 14.90%
FCF Margin 15.82%

Dividends & Yields

This stock pays an annual dividend of $4.81, which amounts to a dividend yield of 1.75%.

Dividend Per Share $4.81
Dividend Yield 1.75%
Earnings Yield 3.75%
FCF Yield 5.19%
Dividend Growth (YoY) 25.66%
Payout Ratio 45.10%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a